CDK-independent role of D-type cyclins in regulating DNA mismatch repair
Gergely Róna, Bearach Miwatani-Minter, Qingyue Zhang, Hailey V. Goldberg, Marc Kerzhnerman, Jesse B. Howard, Daniele Simoneschi, Ethan Lane, John W. Hobbs, Elizabeth Sassani, Andrew Wang, Sarah Keegan, Daniel J. Laverty, Cortt G. Piett, Lőrinc Sándor Pongor, Miranda L. Xu, Joshua Andrade, Anish Thomas, Piotr Siciński, Manor Askenazi, Beatrix Ueberheide, David Fenyö, Zachary D. Nagel, Michele Pagano
Abstract
Although mismatch repair (MMR) is essential for correcting DNA replication errors, it can also recognize other lesions, such as oxidized bases. In G0 and G1, MMR is kept in check through unknown mechanisms as it is error-prone during these cell cycle phases. We show that in mammalian cells, D-type cyclins are recruited to sites of oxidative DNA damage in a PCNA- and p21-dependent manner. D-type cyclins inhibit the proteasomal degradation of p21, which competes with MMR proteins for binding to PCNA, thereby inhibiting MMR. The ability of D-type cyclins to limit MMR is CDK4- and CDK6-independent and is conserved in G0 and G1. At the G1/S transition, the timely, cullin-RING ubiquitin ligase (CRL)-dependent degradation of D-type cyclins and p21 enables MMR activity to efficiently repair DNA replication errors. Persistent expression of D-type cyclins during S-phase inhibits the binding of MMR proteins to PCNA, increases the mutational burden, and promotes microsatellite instability.